Cargando…
Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is typically accompanied by abundant arterial blood flow. Although angiogenic growth factors such as Angiopoietin 2 (Ang2) play a central role in tumor angiogenesis in HCC, the role of serum Ang2 as a biomarker in HCC remains unclear. In this study, we aimed to investi...
Autores principales: | Ao, Junjie, Chiba, Tetsuhiro, Kanzaki, Hiroaki, Kanayama, Kengo, Shibata, Shuhei, Kurosugi, Akane, Iwanaga, Terunao, Kan, Motoyasu, Sakuma, Takafumi, Qiang, Na, Ma, Yaojia, Kojima, Ryuta, Kusakabe, Yuko, Nakamura, Masato, Kobayashi, Kazufumi, Kiyono, Soichiro, Kanogawa, Naoya, Saito, Tomoko, Nakagawa, Ryo, Kondo, Takayuki, Ogasawara, Sadahisa, Suzuki, Eiichiro, Nakamoto, Shingo, Muroyama, Ryosuke, Tawada, Akinobu, Kato, Jun, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Naoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040723/ https://www.ncbi.nlm.nih.gov/pubmed/33854629 http://dx.doi.org/10.7150/jca.56436 |
Ejemplares similares
-
Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus
por: Ma, Yaojia, et al.
Publicado: (2022) -
Switching to systemic therapy after locoregional treatment failure: Definition and best timing
por: Ogasawara, Sadahisa, et al.
Publicado: (2020) -
Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience
por: Ogawa, Keita, et al.
Publicado: (2022) -
Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma
por: Suzuki, Eiichiro, et al.
Publicado: (2014) -
The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
por: Kanzaki, Hiroaki, et al.
Publicado: (2021)